These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 33882328

  • 1. Novel water soluble sterile natamycin formulation (Natasol) for fungal keratitis.
    Velpandian T, Nirmal J, Sharma HP, Sharma S, Sharma N, Halder N.
    Eur J Pharm Sci; 2021 Aug 01; 163():105857. PubMed ID: 33882328
    [Abstract] [Full Text] [Related]

  • 2. Determination of surgical outcomes with a novel formulation of intrastromal natamycin in recalcitrant fungal keratitis: A pilot study.
    Saluja G, Sharma N, Agarwal R, Sharma HP, Maharana P, Satpathy G, Titiyal JS, Velpandian T.
    Indian J Ophthalmol; 2021 Oct 01; 69(10):2670-2674. PubMed ID: 34571612
    [Abstract] [Full Text] [Related]

  • 3. Comparative Evaluation of Topical Monotherapy (Natamycin or Natasol) and Combination Therapy (Natamycin and Voriconazole) in Mild-Moderate Fungal Keratitis.
    Reddy DC, Asif MI, Bari A, Velpandian T, Agarwal T, Maharana PK, Sinha R, Satpathy G, Dada T, Titiyal JS, Sharma N.
    Cornea; 2024 Sep 20. PubMed ID: 39312711
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
    Edwar L, Janna YM, Rozaliyani A, Louisa M.
    Mycoses; 2020 Oct 20; 63(10):1128-1132. PubMed ID: 32780874
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of intrastromal injection of 5% natamycin in experimental fusarium keratitis.
    Mimouni M, Tam G, Paitan Y, Kidron D, Segev F.
    J Ocul Pharmacol Ther; 2014 Sep 20; 30(7):543-7. PubMed ID: 24919100
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nanomicelles empower natamycin in treating fungal keratitis: An in vitro, ex vivo and in vivo study.
    Sathe P, Kailasam V, Nagarjuna V, Sharma H, Velpandian T, Garg P, Nirmal J.
    Int J Pharm; 2024 May 10; 656():124118. PubMed ID: 38615806
    [Abstract] [Full Text] [Related]

  • 10. Fungal keratitis caused by Scopulariopsis brevicaulis treated successfully with natamycin.
    Malecha MA.
    Cornea; 2004 Mar 10; 23(2):201-3. PubMed ID: 15075891
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Secondary pseudomonas infection of fungal keratitis following use of contaminated natamycin eye drops: a case series.
    Krishnan T, Sengupta S, Reddy PR, Ravindran RD.
    Eye (Lond); 2009 Feb 10; 23(2):477-9. PubMed ID: 18820656
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis.
    Kalavathy CM, Parmar P, Kaliamurthy J, Philip VR, Ramalingam MD, Jesudasan CA, Thomas PA.
    Cornea; 2005 May 10; 24(4):449-52. PubMed ID: 15829804
    [Abstract] [Full Text] [Related]

  • 15. Reduced administration frequency for the treatment of fungal keratitis: a sustained natamycin release from a micellar solution.
    Guo Y, Karimi F, Fu Q, G Qiao G, Zhang H.
    Expert Opin Drug Deliv; 2020 Mar 10; 17(3):407-421. PubMed ID: 32009483
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
    El-Nabarawi MA, Abd El Rehem RT, Teaima M, Abary M, El-Mofty HM, Khafagy MM, Lotfy NM, Salah M.
    Drug Dev Ind Pharm; 2019 Jun 10; 45(6):922-936. PubMed ID: 30744431
    [Abstract] [Full Text] [Related]

  • 20. Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis.
    Prajna NV, Radhakrishnan N, Lalitha P, Austin A, Ray KJ, Keenan JD, Porco TC, Lietman TM, Rose-Nussbaumer J.
    Ophthalmology; 2020 Feb 10; 127(2):159-166. PubMed ID: 31619359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.